Development and validation of a human brown adipocyte system

人类棕色脂肪细胞系统的开发和验证

基本信息

  • 批准号:
    8904122
  • 负责人:
  • 金额:
    $ 22.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The activation and recruitment of brown adipose tissue has become an exciting target in the fight against obesity and its related metabolic diseases. Brown adipose tissue differs from white adipose tissue in its critical ability to burn energy as heat through UCP-1 driven adaptive thermogenesis. Expression of mitochondrial UCP-1 uncouples oxidative phosphorylation, resulting in accelerated substrate oxidation but low ATP production. The resulting dissipation of energy is associated with plasma triglyceride clearance, a key factor in weight loss. The brown adipose depot has long been known to exist in rodents as well as in human infants. However, recent evidence has demonstrated the existence of active brown adipose tissue in human adults. These findings prompted a resurgence of research focusing on both the activation of brown adipose tissue and the "browning" of white adipose tissue, a phenomenon wherein UCP-1-mediated mitochondrial uncoupling is induced by stimuli. Studies using rodent models have demonstrated that brown fat activation or induction of browning can promote beneficial metabolic effects, and promising therapeutic targets have been identified. However, the therapeutic potential of these targets has not been confirmed due to the lack of a widely available human brown adipocyte model. Therefore, there is a pronounced need to validate existing therapeutic targets in the human system. ZenBio will address this need by providing both a primary and immortalized human brown adipocyte cell culture system to the research community and will utilize these tools to establish a screen to identify activators of human brown adipogenesis. The principal goal of this project is to generate and characterize a human adult brown adipocyte cell system. We will achieve this in a stepwise fashion, beginning with an initial feasibility study focused on human fetal brown adipocytes. Aim I will use functional and genomic analyses to generate a widely available fetal brown adipocyte model which will be used as a tool to establish the adult cell system. The fetal model will be developed first due to the comparative ease of detecting fetal brown adipose tissue and its ready availability through existing procurement agencies. The second aim is to generate and characterize an immortalized fetal brown adipocyte system for high throughput/high content screening. These cells will circumvent the limited material and lifespan of primary cells and allow for the development of a high throughput screening platform to identify novel targets of brown adipocyte activation. Phase I will be expanded in Phase II with the goal of characterizing and commercializing the human adult brown adipocyte system from donors of differing BMI, age, gender and diabetic state. These studies will generate both primary and immortalized human adult adipocyte cells which will be used to identify novel targets of brown adipocyte energy expenditure for the treatment of obesity.
 描述(由申请人提供):棕色脂肪组织的激活和募集已成为对抗肥胖及其相关代谢疾病的令人兴奋的目标。棕色脂肪组织与白色脂肪组织的不同之处在于其通过 UCP 将能量燃烧为热量的关键能力。 -1 驱动适应性生热作用。线粒体 UCP-1 的表达解偶联氧化磷酸化,导致底物氧化加速,但 ATP 产生较低,从而导致能量耗散。血浆甘油三酯清除率是减肥的关键因素,长期以来人们都知道棕色脂肪库存在于啮齿类动物和人类婴儿中,但最近的证据表明,成年人体内也存在活跃的棕色脂肪组织。关注棕色脂肪组织激活和白色脂肪组织“褐变”的研究重新兴起,这种现象导致 UCP-1 介导的线粒体解偶联,是由啮齿动物模型的刺激引起的。已经证明,棕色脂肪的激活或诱导褐变可以促进有益的代谢作用,并且已经确定了有希望的治疗靶标,但是,由于缺乏广泛可用的人类棕色脂肪细胞模型,这些靶标的治疗潜力尚未得到证实。迫切需要验证人体系统中的现有治疗靶点,ZenBio 将通过向研究界提供原代和永生化人类棕色脂肪细胞培养系统来满足这一需求,并将利用这些工具建立筛选来识别激活剂。人类棕色脂肪生成。该项目的主要目标是生成并表征人类成人棕色脂肪细胞系统,我们将从针对人类胎儿棕色脂肪细胞的初步可行性研究开始,逐步实现这一目标。广泛使用的胎儿棕色脂肪细胞模型将被用作建立成人细胞系统的工具,因为检测胎儿棕色脂肪细胞组织相对容易并且可以通过现有采购机构获得。目的是生成并表征用于高通量/高内涵筛选的永生化胎儿棕色脂肪细胞系统将规避原代细胞的有限材料和寿命,并允许开发高通量筛选平台来识别棕色脂肪细胞激活的新靶点。第二阶段的目标是对来自不同体重指数、年龄、性别和糖尿病状态的捐赠者的成人棕色脂肪细胞系统进行表征和商业化,这些研究将产生原代和永生化的成人脂肪细胞,用于鉴定。棕色脂肪细胞能量消耗治疗肥胖的新目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOLANDA Renee LEA-CURRIE其他文献

YOLANDA Renee LEA-CURRIE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOLANDA Renee LEA-CURRIE', 18)}}的其他基金

Tuned stem cell extracellular vesicles as a novel chronic wound therapeutic
调整干细胞细胞外囊泡作为新型慢性伤口治疗剂
  • 批准号:
    9465841
  • 财政年份:
    2017
  • 资助金额:
    $ 22.43万
  • 项目类别:
Tuned stem cell extracellular vesicles are a novel chronic wound therapeutic
调谐干细胞胞外囊泡是一种新型慢性伤口治疗剂
  • 批准号:
    10022443
  • 财政年份:
    2017
  • 资助金额:
    $ 22.43万
  • 项目类别:
Diabetes Therapies from Adipose Derived Stem Cells
脂肪干细胞的糖尿病治疗
  • 批准号:
    7992863
  • 财政年份:
    2010
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of Human Omental Mesothelial Cells for Research
人类网膜间皮细胞的商业化研究
  • 批准号:
    7326709
  • 财政年份:
    2007
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of a Human Myocyte and Adipocyte Co-Culture System
人类心肌细胞和脂肪细胞共培养系统的商业化
  • 批准号:
    7692905
  • 财政年份:
    2007
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of a Human Myocyte and Adipocyte Co-Culture System
人类心肌细胞和脂肪细胞共培养系统的商业化
  • 批准号:
    7270329
  • 财政年份:
    2007
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of a Human Myocyte and Adipocyte Co-Culture System
人类心肌细胞和脂肪细胞共培养系统的商业化
  • 批准号:
    7611887
  • 财政年份:
    2007
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of Human Mesothelial Cells for Research
人类间皮细胞的商业化研究
  • 批准号:
    7758734
  • 财政年份:
    2007
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of Human Visceral Adipocytes
人内脏脂肪细胞的商业化
  • 批准号:
    6689059
  • 财政年份:
    2003
  • 资助金额:
    $ 22.43万
  • 项目类别:
Commercialization of Human Visceral Adipocytes
人内脏脂肪细胞的商业化
  • 批准号:
    6989857
  • 财政年份:
    2003
  • 资助金额:
    $ 22.43万
  • 项目类别:

相似国自然基金

巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
  • 批准号:
    32300573
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
不同脂肪组织及其驻留巨噬细胞调控小鼠禁食稳态的系统研究
  • 批准号:
    32301235
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
  • 批准号:
    82301753
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
有氧康复运动抑制心外膜脂肪组织Th17细胞分化改善HFpEF所致心房颤动实验研究
  • 批准号:
    82372581
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
MYO9B缺失调控脂肪组织巨噬细胞代谢重编程促进肥胖相关胰岛素抵抗的机制研究
  • 批准号:
    82300948
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
Them1 治疗非酒精性脂肪肝的抑制剂
  • 批准号:
    10666090
  • 财政年份:
    2023
  • 资助金额:
    $ 22.43万
  • 项目类别:
PDGFRB Signaling in Progressive Skin Disease
进行性皮肤病中的 PDGFRB 信号传导
  • 批准号:
    10583948
  • 财政年份:
    2023
  • 资助金额:
    $ 22.43万
  • 项目类别:
Mechanical properties of adipose tissue and its effect on breast cancer
脂肪组织的力学特性及其对乳腺癌的影响
  • 批准号:
    10737165
  • 财政年份:
    2023
  • 资助金额:
    $ 22.43万
  • 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
  • 批准号:
    10703523
  • 财政年份:
    2023
  • 资助金额:
    $ 22.43万
  • 项目类别:
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 22.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了